Medicines Position Statements – NEL NEL Branded generics LPP and London Diabetes Network joint statement: Access to continuous glucose monitors for adults living with type 2 diabetes in London IQoro® position statement for hiatus hernia and reflux, stroke-related dysphagia and other indications (NEL)_02.2024 Position statement on generic and brand prescribing (NEL) Preferred DOAC prescribing position statement (NEL)_04.2024 Initiation of statins for primary prevention of cardiovascular disease in patients with Liver disease